Avalo Therapeutics, Inc. (AVTX)
Nasdaq: AVTX · CIK 0001534120 · United States
Every official Avalo Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AVTX filings
Avalo Therapeutics, Inc. documents
- Avalo Therapeutics, Inc. 10-K 2026AVTX 10-K 2026: annual report for fiscal 2026
- Avalo Therapeutics, Inc. 10-K 2025AVTX 10-K 2025: annual report for fiscal 2025
- Avalo Therapeutics, Inc. 10-K 2024AVTX 10-K 2024: annual report for fiscal 2024
- Avalo Therapeutics, Inc. 10-K 2023AVTX 10-K 2023: annual report for fiscal 2023
- Avalo Therapeutics, Inc. 10-K 2022AVTX 10-K 2022: annual report for fiscal 2022
- Avalo Therapeutics, Inc. 10-Q 2026AVTX 10-Q 2026: quarterly report for fiscal 2026
- Avalo Therapeutics, Inc. 10-Q 2025AVTX 10-Q 2025: quarterly report for fiscal 2025
- Avalo Therapeutics, Inc. 10-Q 2024AVTX 10-Q 2024: quarterly report for fiscal 2024
- Avalo Therapeutics, Inc. 10-Q 2023AVTX 10-Q 2023: quarterly report for fiscal 2023
- Avalo Therapeutics, Inc. 10-Q 2022AVTX 10-Q 2022: quarterly report for fiscal 2022
- Avalo Therapeutics, Inc. 8-K 2026AVTX 8-K 2026: current report for fiscal 2026
- Avalo Therapeutics, Inc. 8-K 2025AVTX 8-K 2025: current report for fiscal 2025
- Avalo Therapeutics, Inc. 8-K 2024AVTX 8-K 2024: current report for fiscal 2024
- Avalo Therapeutics, Inc. 8-K 2023AVTX 8-K 2023: current report for fiscal 2023
- Avalo Therapeutics, Inc. 8-K 2022AVTX 8-K 2022: current report for fiscal 2022
- Avalo Therapeutics, Inc. DEF 14A 2026AVTX DEF 14A 2026: proxy statement for fiscal 2026
- Avalo Therapeutics, Inc. DEF 14A 2025AVTX DEF 14A 2025: proxy statement for fiscal 2025
- Avalo Therapeutics, Inc. DEF 14A 2024AVTX DEF 14A 2024: proxy statement for fiscal 2024
- Avalo Therapeutics, Inc. DEF 14A 2023AVTX DEF 14A 2023: proxy statement for fiscal 2023
- Avalo Therapeutics, Inc. DEF 14A 2022AVTX DEF 14A 2022: proxy statement for fiscal 2022
- Avalo Therapeutics, Inc. Form 4 2026AVTX Form 4 2026: insider trading filing for fiscal 2026
- Avalo Therapeutics, Inc. Form 4 2025AVTX Form 4 2025: insider trading filing for fiscal 2025
- Avalo Therapeutics, Inc. Form 4 2024AVTX Form 4 2024: insider trading filing for fiscal 2024
- Avalo Therapeutics, Inc. Form 4 2023AVTX Form 4 2023: insider trading filing for fiscal 2023
- Avalo Therapeutics, Inc. Form 4 2022AVTX Form 4 2022: insider trading filing for fiscal 2022
- Avalo Therapeutics, Inc. S-1 2026AVTX S-1 2026: registration statement for fiscal 2026
- Avalo Therapeutics, Inc. S-1 2025AVTX S-1 2025: registration statement for fiscal 2025
- Avalo Therapeutics, Inc. S-1 2024AVTX S-1 2024: registration statement for fiscal 2024
- Avalo Therapeutics, Inc. S-1 2023AVTX S-1 2023: registration statement for fiscal 2023
- Avalo Therapeutics, Inc. S-1 2022AVTX S-1 2022: registration statement for fiscal 2022
- Avalo Therapeutics, Inc. 13F 2026AVTX 13F 2026: institutional holdings for fiscal 2026
- Avalo Therapeutics, Inc. 13F 2025AVTX 13F 2025: institutional holdings for fiscal 2025
- Avalo Therapeutics, Inc. 13F 2024AVTX 13F 2024: institutional holdings for fiscal 2024
- Avalo Therapeutics, Inc. 13F 2023AVTX 13F 2023: institutional holdings for fiscal 2023
- Avalo Therapeutics, Inc. 13F 2022AVTX 13F 2022: institutional holdings for fiscal 2022
More companies